However, these changes were no longer present in patients aged 65–75 years and in patients > 75 years after adjustment for tumour characteristics (including tumour grade, stage, hormone-receptor status and HER2 status), while it remained statistically significant in the youngest age group. Here, NR4A1 is linked to neoplasm.